583
Participants
Start Date
April 4, 2014
Primary Completion Date
March 19, 2018
Study Completion Date
March 19, 2018
Etanercept
Patients received biosimilar etanercept 25 mg twice weekly or 50 mg once weekly.
Connective Diseases Research Center, Tabriz University of Medical Sciences, Tabriz
Hafez Hospital, Shiraz
Razi Hospital, Rasht
Ghaem Hospital, Mashhad
Golestan Hospital, Ahvāz
Alzahra Hospital, Isfahan
Personal Office, Isfahan
Kerman University of Medical Sciences, Kerman
Personal Office, Shiraz
Rheumatology Research Center, Tehran University of Medical Sciences, Tehran
Lead Sponsor
AryoGen Pharmed Co.
INDUSTRY